Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
09:00am, Thursday, 12'th Dec 2024
SAN FRANCISCO--(BUSINESS WIRE)--For most Americans, weight is more than just a number. It shapes our health, our mood, our confidence, our spending, and the decisions we make in our day to day lives.
Hims & Hers: Look At What Matters Most
04:51am, Thursday, 12'th Dec 2024
Hims & Hers Health, Inc. has shown significant improvement in key unit economics, positioning it among top-tier SaaS companies in terms of scalability and growth potential. The company reported stella
4 Stocks That Crushed Analyst Estimates by More Than Double
07:01am, Wednesday, 11'th Dec 2024
Every earnings season has its share of winners and losers, as well as top and bottom-line surprises and disappointments. This recent earnings season is no different.
Options Action: Bearish bets on Hims
06:50pm, Tuesday, 10'th Dec 2024
Mike Khouw joins 'Fast Money' to talk the options trade around Hims.
Market Navigator: Hims & Hers Health up 250% in 2024
03:23pm, Tuesday, 10'th Dec 2024
Todd Gordon, founder of Inside Edge Capital, joins CNBC's 'Power Lunch' to discuss why he's keeping an eye on shares of these healthcare picks, potential headwinds, and more.
Hims & Hers: The Show Must Go On
09:30am, Thursday, 05'th Dec 2024
Hims & Hers Health stock is substantially undervalued despite a massive YTD rally, presenting a strong buy opportunity due to a myriad of catalysts. The company demonstrates exponential revenue growth
Stock Picks From Seeking Alpha's November 2024 New Analysts
08:30am, Thursday, 05'th Dec 2024
Twenty-six new analysts joined Seeking Alpha in November, sharing diverse investment ideas highlighting their unique backgrounds and expertise. Top picks include U.S. Bancorp Preferred Series A, Hersh
2 Telehealth Stocks That Could Gain from Trump's New FDA Pick
08:15am, Thursday, 05'th Dec 2024
The Trump administration has nominated Dr. Marty Makary for the role of the United States Federal Drug Administration (FDA) commissioner. Dr. Makary is the Chief of Islet Transplant Surgery at Johns H
Hims & Hers Vs. Amazon: Why David Defeats Goliath
06:16am, Thursday, 05'th Dec 2024
Hims & Hers has shown significant growth in the telehealth market, facing competition mainly from Amazon, but has unique advantages. HIMS's agility, focused resource allocation, and strong market fit
Hims & Hers Named to Inc.'s 2024 Best in Business List in Health Products Category
12:58pm, Tuesday, 03'rd Dec 2024
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, is proud to announce its inclusion on the Inc. 2024 Best in Business
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know
10:01am, Tuesday, 03'rd Dec 2024
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.
Hims & Hers: Driving Growth In Wellness
10:34am, Friday, 29'th Nov 2024
Hims & Hers achieved a 44% YoY increase in Q3 2024, surpassing 2 million active users. Q3 2024 revenue rose 77% YoY to $401.6M, with $392.6M from online channels (+79% YoY). GLP-1 patient retention at
Why Hims & Hers Stock Jumped on Massive FDA News
12:07pm, Tuesday, 26'th Nov 2024
Shares of Hims & Hers (HIMS 0.67%) jumped as much as 23% in trading on Monday after President Trump announced his new Food and Drug Administration (FDA) chief, who happens to have ties to a business s
Mizuho's Jared Holz on what Trump's FDA pick means for biotech innovation
06:44pm, Monday, 25'th Nov 2024
Mizuho's Jared Holz joins 'Fast Money' to talk what's next for biopharma space after president-elect Trump names his pick for FDA head.
Him & Hers Health Stock Doubled Options Bulls' Money
03:11pm, Monday, 25'th Nov 2024
Schaeffer's Weekend Trader subscribers scored a big win just in time for Thanksgiving.
